Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Weighing the Risks of AI Tools, From Demographic Bias to Privacy Violations

With Microsoft announcing a multibillion dollar investment into ChatGPT, Google launching Bard, and China’s search engine giant Baidu, Inc. entering the race with Ernie, the AI party has officially begun. More companies are integrating ChatGPT into their daily operations as the tool proves itself as flexible for a variety of use cases, and adoption…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

With Microsoft announcing a multibillion dollar investment into ChatGPT, Google launching Bard, and China’s search engine giant Baidu, Inc. entering the race with Ernie, the AI party has officially begun. More companies are integrating ChatGPT into their daily operations as the tool proves itself as flexible for a variety of use cases, and adoption is hot; the number of users on ChatGPT crossed 100 million over a month ago. However, even with all this use case validation and excitement around generative AI’s possibilities, experts are increasingly warning against the risks of AI.

Recently, the Federal Trade Commission (FTC) warned companies against making baseless claims and failing to see the risks posed by their AI-enabled products. The warning comes nearly two years after the FTC had raised concerns about the “troubling outcomes” produced by some AI tools. Here, the FTC pointed out how an algorithm in the healthcare industry was found to show racial bias. And a few years ago, Amazon found that its recruiting tool discriminated against women.

In the past, the FTC has fined Facebook billions of dollars for violating users’ privacy through its facial recognition software. Even White Castle, a hamburger chain, could face a fine worth billions of dollars for the automated collection and sharing of the biometric data of its employees without prior consent.

Scott Sereboff, the general manager for the North American for Deeping Source, a spatial analytics company that offers software for businesses to collect physical and virtual data without infringing on individual customers’ or employees’ privacy, gives his perspectives on the risks of AI and why he has been on a campaign to highlight its ethical uses.

Scott’s Thoughts:

When it comes to artificial intelligence, machine learning and the things that go with it, perhaps the key topic on which industry thought leaders should be focused is ethics and morality, and where we’re going with this and how we’re going to use it. The benefits of AI and machine learning are probably too numerous to count, but are we letting it grow past our ability to guide and shape it into something that is at least more difficult to use in a negative way. The conversations that all these industry experts should be having are around that — demystifying AI and machine learning, helping people to understand that at the end of every one of these algorithmic chains is a human who has either programmed it or categorized the data or has had a hand in determining the shaping of a database or of the AI itself. The part of this process that becomes scary is if we can write the ultimate AI for good programming in any subset (facial recognition, voice recognition), so too can a bad person write the fascist version or the apartheid version. IBM assisted the South African government in the creation of a database that was used for the suppression of black South Africans.

Now with every part of the AI development process, there’s something important consider in light of how it is or is not regulated. In the United States, we don’t really have a specified GDPR-style legislation. Illinois has an incredibly tough legislation, however and California too.

Another discussion we should really be having is about potential legal ramifications. Are you and your company protected against the potential legal trouble you can find yourself in if you reveal personal information or take personal information from a person without his/her permission? It is a legal gray area but are we paying enough attention to that topic as well?

Let’s say I’m running a multistage corporation that has front-end retail or shopping or a hospital network and I’ve got some sort of AI that is collecting data through video cameras or audio interfaces or gate analysis. The questions I must ask is: am I paying attention to whether or not this can be used to track everything back to me?

I don’t know if everyone realizes the potential danger and with what just happened in Illinois with the White Castle case, although it’s certainly — I should say, almost certainly — not going to wind up as bad as it is right now. The industry’s response to it has been one of surprise, and yet, why are they surprised?

We have spent decades watching social media become this incredibly divisive sort of societal upheaval mechanism. If we’re not careful and we don’t keep an eye on what we’re doing with artificial intelligence, it will do exactly the same thing and history will repeat itself. It’s really easy to say, ‘I’m not prejudiced. The database made me do it.’ So I would suggest that across all of the three questions you’ve asked, the key topics, important conversations, important questions, are all questions around morality and ethics.”

Article written by Aarushi Maheswhari

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

AlphaGenome Atlas gives researchers predicted molecular effects for possible DNA changes across the human genome, helping teams prioritize variants for experimental follow-up.

  • 01The Atlas covers roughly nine billion possible single-letter DNA substitutions, according to The Verge.
  • 02Predictions can prioritize research questions but do not establish clinical findings.
  • 03The useful implementation pattern is prediction, study-specific evidence, then validation.

Sep 9, 2026

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI says roughly 10,000 AI agents produced a proposed Navier–Stokes solution in 88 hours, followed by Lean verification. For healthcare and life sciences, the immediate signal is a research workflow built around parallel agents, code execution, provenance and formal checking—not a ready-made clinical simulator.

  • 01OpenAI's result is a proposed proof under review, not a new clinical simulation product.
  • 02The near-term B2B signal is a coordinated research stack combining agents, code and formal verification.
  • 03Healthcare buyers should evaluate provenance, reproducibility, security and cost per validated result.

Sep 9, 2026

Get  checked out

Get checked out

Seeking medical evaluation immediately after a vehicle crash, regardless of how you feel, is essential because adrenaline can mask serious injuries for hours or even up to a full day. A same-day medical visit creates a documented paper trail tied to the accident date, which protects against insurance companies disputing injury claims and denying compensation.

  • 01Feeling fine immediately after a vehicle crash may not accurately reflect one's health condition.
  • 02The body's response to stress can delay the onset of injury symptoms.
  • 03Seek medical evaluation after a crash, even if injuries aren't immediately apparent.

Sep 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512